High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas

Acta Neuropathologica

Volumn 118, Issue 6, 2009, Pages 745-754

  Colin, Carole ^a   Voutsinos Porche, Brigitte ^a   Nanni, Isabelle ^b   Fina, Frédéric ^b   Metellus, Philippe ^b   Intagliata, Dominique ^a   Baeza, Nathalie ^a   Bouvier, Corinne ^a,b   Delfino, Christine ^a   Loundou, Anderson ^b   Chinot, Olivier ^b   Lah, Tamara ^c   Kos, Janko ^d   Martin, Pierre Marie ^b   Ouafik, L'Houcine ^a   Figarella Branger, Dominique ^a,b  

^a University of the Mediterranean Aix Marseille II   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cathepsin B; Glioblastomas; Invasion process; PAI 1; Prognostic biomarker; Proteases

Indexed keywords

CATHEPSIN B; GELATINASE A; GELATINASE B; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COHORT ANALYSIS; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PILOCYTIC ASTROCYTOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CATHEPSIN B; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 71449101202     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0592-2     Document Type: Article

References (37)

1. AC Bellail SB Hunter DJ Brat C Tan EG Van Meir 2004 Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion Int J Biochem Cell Biol 36 1046 1069 10.1016/j.biocel.2004.01.013 1:CAS:528:DC%2BD2cXjt1ant7o%3D 15094120 (Pubitemid 38501557)
2. AK Bindal M Hammoud WM Shi SZ Wu R Sawaya JS Rao 1994 Prognostic significance of proteolytic enzymes in human brain tumors J Neurooncol 22 101 110 10.1007/BF01052886 1:STN:280:DyaK2M3msVWqsQ%3D%3D 7538161
3. X Bu X Zhang W Cao 1998 The expression of plasminogen activator inhibitor-1 (PAI-1) gene in human astrocytomas Zhonghua Bing Li Xue Za Zhi 27 433 435 1:STN:280:DC%2BD3M3jsV2qtw%3D%3D 11244954
4. DV Caccamo ME Keohane PE McKeever 1994 Plasminogen activators and inhibitors in gliomas: an immunohistochemical study Mod Pathol 7 99 104 1:STN:280:DyaK2c3htFOmsw%3D%3D 8159659
5. MR Chicoine DL Silbergeld 1995 The in vitro motility of human gliomas increases with increasing grade of malignancy Cancer 75 2904 2909 10.1002/1097-0142(19950615)75:12<2904::AID-CNCR2820751218>3.0.CO;2-2 1:STN:280:DyaK2M3pt1altw%3D%3D 7773941
6. SK Chintala JC Tonn JS Rao 1999 Matrix metalloproteinases and their biological function in human gliomas Int J Dev Neurosci 17 495 502 10.1016/S0736-5748(99)00010-6 1:CAS:528:DC%2BD3cXhtlyqug%3D%3D 10571411 (Pubitemid 29421836)
7. P Chomczynski N Sacchi 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 156 159 10.1016/0003-2697(87)90021-2 1:CAS:528:DyaL2sXitFSns7Y%3D 2440339
8. A Claes AJ Idema P Wesseling 2007 Diffuse glioma growth: a guerilla war Acta Neuropathol 114 443 458 10.1007/s00401-007-0293-7 17805551 (Pubitemid 47521501)
9. C Colin N Baeza C Bartoli, et al. 2006 Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization Oncogene 25 2818 2826 10.1038/sj.onc. 1209305 1:CAS:528:DC%2BD28XktVGrs7w%3D 16314830
10. C Colin I Virard N Baeza, et al. 2007 Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis Neuropathol Appl Neurobiol 33 431 439 10.1111/j.1365-2990.2007.00829.x 1:CAS:528:DC%2BD2sXpslOlsbg%3D 17442061 (Pubitemid 47037890)
11. LL Demchik M Sameni K Nelson T Mikkelsen BF Sloane 1999 Cathepsin B and glioma invasion Int J Dev Neurosci 17 483 494 10.1016/S0736-5748(99)00011-8 1:CAS:528:DC%2BD3cXhtlyqtQ%3D%3D 10571410 (Pubitemid 29421835)
12. A Giese R Bjerkvig ME Berens M Westphal 2003 Cost of migration: invasion of malignant gliomas and implications for treatment J Clin Oncol 21 1624 1636 10.1200/JCO.2003.05.063 1:STN:280:DC%2BD3s7nvFWitw%3D%3D 12697889 (Pubitemid 46594118)
13. Gole B, Duran Alonso MB, Dolenc V, Lah T (2009) Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro. Pathol Oncol Res [Epub ahead of print]
14. J Gu C Zhang R Chen, et al. 2009 Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas Eur J Pediatr 168 705 710 10.1007/s00431-008-0828-5 1:CAS:528:DC%2BD1MXmvV2ktLc%3D 18795327
15. ME Hegi AC Diserens T Gorlia, et al. 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997 1003 10.1056/NEJMoa043331 1:CAS:528:DC%2BD2MXit1Wktro%3D 15758010 (Pubitemid 40349502)
16. DW Hsu JT Efird ET Hedley-Whyte 1995 Prognostic role of urokinase-type plasminogen activator in human gliomas Am J Pathol 147 114 123 1:STN:280:DyaK2MzivVKjtQ%3D%3D 7604873
17. PJ Kelly C Daumas-Duport DB Kispert BA Kall BW Scheithauer JJ Illig 1987 Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms J Neurosurg 66 865 874 10.3171/jns.1987.66.6.0865 1:STN:280: DyaL2s7pslGqtw%3D%3D 3033172
18. D Krex B Klink C Hartmann, et al. 2007 Long-term survival with glioblastoma multiforme Brain 130 2596 2606 10.1093/brain/awm204 17785346 (Pubitemid 47511715)
19. K Kunishio M Okada Y Matsumoto S Nagao 2003 Matrix metalloproteinase-2 and -9 expression in astrocytic tumors Brain Tumor Pathol 20 39 45 10.1007/BF02483445 1:CAS:528:DC%2BD2sXjtF2js7o%3D 14756439 (Pubitemid 38146269)
20. TT Lah T Strojnik N Levicar, et al. 2000 Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors Int J Biol Markers 15 90 93 1:CAS:528:DC%2BD3cXivF2nurg%3D 10763148
21. Lah TT, Obermajer N, Duran-Alonso MB, Kos J (2008) The cancer degradome; proteases and cancer biology: cysteine cathepsins and cystatins as cancer biomarkers. Springer, New York
22. SS Lakka CS Gondi N Yanamandra, et al. 2004 Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis Oncogene 23 4681 4689 10.1038/sj.onc.1207616 1:CAS:528:DC%2BD2cXks1Klsbc%3D 15122332 (Pubitemid 38859457)
23. BJ Landau HC Kwaan EN Verrusio SS Brem 1994 Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors Cancer Res 54 1105 1108 1:STN:280: DyaK2c7ksleqsQ%3D%3D 8313368
24. N Levicar RK Nuttall TT Lah 2003 Proteases in brain tumour progression Acta Neurochir (Wien) 145 825 838 10.1007/s00701-003-0097-z 1:STN:280: DC%2BD3svktlGhtw%3D%3D (Pubitemid 37204559)
25. DN Louis H Ohgaki OD Wiestler, et al. 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 10.1007/s00401-007-0243-4 17618441
26. NF Marko SA Toms GH Barnett R Weil 2008 Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study Genomics 91 395 406 10.1016/j.ygeno.2008.01.002 1:CAS:528:DC%2BD1cXkvVeksbw%3D 18343632
27. R Martinez G Schackert R Yaya-Tur I Rojas-Marcos JG Herman M Esteller 2007 Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme J Neurooncol 83 91 93 10.1007/s11060-006- 9292-0 1:CAS:528:DC%2BD2sXmtVCqs7s%3D 17164975 (Pubitemid 46647170)
28. T Mikkelsen PS Yan KL Ho M Sameni BF Sloane ML Rosenblum 1995 Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis J Neurosurg 83 285 290 10.3171/jns.1995.83.2.0285 1:STN:280:DyaK2MzktFemtg%3D%3D 7542317
29. X Muracciole S Romain H Dufour, et al. 2002 PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification Int J Radiat Oncol Biol Phys 52 592 598 10.1016/S0360-3016(01)02699-2 1:CAS:528: DC%2BD38XhtF2jtL8%3D 11849778 (Pubitemid 34158718)
30. A Nakano E Tani K Miyazaki Y Yamamoto J Furuyama 1995 Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas J Neurosurg 83 298 307 10.3171/jns.1995.83.2.0298 1:STN:280:DyaK2MzktFemtA%3D%3D 7616276
31. H Ohgaki P Dessen B Jourde, et al. 2004 Genetic pathways to glioblastoma: a population-based study Cancer Res 64 6892 6899 10.1158/0008-5472.CAN-04-1337 1:CAS:528:DC%2BD2cXotFalsrc%3D 15466178 (Pubitemid 39330996)
32. JS Rao 2003 Molecular mechanisms of glioma invasiveness: the role of proteases Nat Rev Cancer 3 489 501 10.1038/nrc1121 1:CAS:528: DC%2BD3sXltVSqtr8%3D 12835669
33. DL Silbergeld MR Chicoine 1997 Isolation and characterization of human malignant glioma cells from histologically normal brain J Neurosurg 86 525 531 10.3171/jns.1997.86.3.0525 1:STN:280:DyaK2s7pvVamtQ%3D%3D 9046311
34. Stoppelli MP, Andersen LM, Votta G, Andreasen PA (2008) The cancer degradome; proteases and cancer biology: engineered antagonists of uPA and PAI-1. Springer, New York
35. T Strojnik J Kos B Zidanik R Golouh T Lah 1999 Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors Clin Cancer Res 5 559 567 1:STN:280:DyaK1M7pvVyjtA%3D%3D 10100707
36. T Strojnik R Kavalar M Trinkaus TT Lah 2005 Cathepsin L in glioma progression: comparison with cathepsin B Cancer Detect Prev 29 448 455 10.1016/j.cdp.2005.07.006 1:CAS:528:DC%2BD2MXht1WjsLnM 16183211 (Pubitemid 41406140)
37. A Tchoghandjian C Fernandez C Colin, et al. 2009 Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature Brain 132 1523 1535 10.1093/brain/awp048 19336457